| William C. Sessa |
William C. Sessa is currently working as the SVP & Chief Scientific Officer-Internal Medicine at Pfizer Inc. |
| Maria Rivas |
Maria Rivas currently works at The Cooper Cos., Inc., as Independent Director from 2021, New Jersey Performing Arts Center Corp., as Director, 50, as Director from 2021, and Pfizer Inc., as Chief Medical Affairs Officer from 2022. Dr. Rivas also formerly worked at Medidata Solutions, Inc., as Independent Director from 2018 to 2019, Eli Lilly & Co., as Head-Women's Health Medical Affairs from 1999 to 2010, Merck & Co., Inc., as Senior Vice President-Global Medical Affairs from 2016 to 2018, Merck KGaA, as Senior VP & Head-Global Medical Affairs from 2016 to 2018, AbbVie, Inc., as Vice President-Global Medical Affairs from 2012 to 2015, EMD Serono, Inc., as Chief Medical Officer & Senior Vice President from 2018 to 2022, Oncology, Inc., as Vice President, and Bayer HealthCare, as Vice President-US General Medicine from 2010 to 2012. Dr. Rivas received her undergraduate degree from Brandeis University and doctorate degree from Columbia University College of Physicians & Surgeons. |
| Jennifer B. Damico |
Jennifer B. Damico is currently working as a Senior Vice President & Controller at Pfizer Inc. She holds an MBA from Pace University. |
| Albert Bourla |
Albert Bourla is currently the Chairman & Chief Executive Officer at Pfizer Inc. He is also the Chairman & Chief Executive Officer at Pfizer Ltd. In addition, he serves as the Co-Chairman at The Partnership for New York City, Inc. and as the Chairman-Elect at Pharmaceutical Research & Manufacturers of America starting in 2024. Bourla is the Chairman of The Pfizer Foundation, Inc. and a Director at Biotechnology Innovation Organization. He is also a Director at Catalyst, Inc. since 2019 and a Director at Healthcare Leadership Council. Furthermore, Bourla is the President of International Federation of Pharmaceutical Manufacturers starting in 2023. He is a Member of Council on Foreign Relations, Inc., a Trustee at United States Council for International Business, and a Member of The Business Roundtable and The Business Council. Bourla holds a doctorate degree from the School of Veterinary Medicine (Greece). |
| Rady A. Johnson |
Rady A. Johnson is currently the Director at Pro Bono Partnership, Inc. and the Director at Citizens Crime Commission of New York City. Previously, he held the position of EVP, Chief Compliance, Quality & Risk Officer at Pfizer Inc. starting in 1994. Before that, he worked as a Member at Hogan & Hartson LLP and as a Senior Auditor at Arthur Anderson & Co. Mr. Johnson completed his undergraduate degree at the University of Richmond and his graduate degree at Georgetown University Law Center. |
| Chris Boshoff |
Chris Boshoff is currently the Chief Oncology Officer & Executive Vice President at Pfizer Inc. He is also the President at Seagen Inc. Additionally, he holds the position of Vice President-Translational Oncology at Pfizer (La Jolla). Previously, he served as a Non-Executive Director at Advanced Oncotherapy Plc in 2013. Dr. Boshoff obtained a doctorate degree from the University of Pretoria. |
| Aida Habtezion |
Aida Habtezion is currently the Director at the PhRMA Foundation, the American Pancreatic Association Inc., and the International Science Reserve. He is also the Chief Medical Officer & Head-Worldwide Medical at Pfizer Inc. Aida is a Member of the New York Academy of Sciences, the Association of American Physicians, and the American Society for Clinical Investigation. Previously, he served as the Associate Dean-Academic Affairs at Stanford University School of Medicine from 2019 to 2023. Aida completed his undergraduate studies at the University of Alberta, his graduate studies at the University of Guelph, and his doctorate at McMaster University. |
| Luis Jodar |
Luis Jodar has a current job as the Chief Medical Officer-Vaccines & Senior VP at Pfizer Inc. |
| Annaliesa Anderson |
Annaliesa Anderson is currently working as the SVP, Head-Vaccine Research & Development at Pfizer Inc. She started this position in 2022. Prior to her current role, Dr. Anderson obtained a doctorate degree from the University of Warwick. |
| Jeff Settleman |
Jeff Settleman is currently the Co-Chief Scientific Officer at Pfizer Inc. and a Member of the Scientific Advisory Board at Trillium Therapeutics ULC. Previously, he worked as the Director of Scientific and Molecular Therapeutics at Massachusetts General Hospital Cancer Center, a Professor at Harvard Medical School, and the Head of Oncology Research at Calico LLC. Settleman received his undergraduate degree from the University of Pennsylvania and his doctorate from Yale University. |
| Michael McDermott |
Michael McDermott is currently the Chief Global Supply Officer & Executive VP at Pfizer Inc. He previously worked as the Director at People-To-People, Inc. and as the Vice President-Site Operations at Wyeth Holdings LLC from 2007 to 2009. McDermott has an undergraduate and graduate degree from the New Jersey Institute of Technology. |
| Alexandre de Germay |
Alexandre de Germay currently works at Laboratoires Majorelle SAS, as Co-Chief Executive Officer from 2021 and Pfizer Inc., as Chief International Commercial Officer & EVP from 2023. Mr. de Germay also formerly worked at Sanofi, as Senior Vice President & Global Head-Cardiovascular. |
| Aamir Malik |
Aamir Malik is currently the Chief Commercial Officer-US & Executive VP at Pfizer Inc. Prior to his current role, he worked at McKinsey & Co., Inc. as the Managing Partner from 1997 to 2021. Aamir also served as a Member of the Dean's Council at Kelley School of Business. He completed his undergraduate degree at Indiana University. |
| Patrice Ettinger |
Patrice Ettinger is currently the Director at the International Association of Privacy Professionals and the Chief Privacy Officer at Pfizer Inc. |
| Payal Sahni Becher |
Payal Sahni Becher is currently the Chief People Experience Officer & Executive VP at Pfizer Inc. She started this position in 2022. Prior to her current role, she obtained a graduate degree from Fairleigh Dickinson University and an undergraduate degree from Rider University. |
| Lidia L. Fonseca |
Lidia L. Fonseca is currently a Director at The U.S.-Japan Business Council, Inc., an Independent Director at Medtronic Plc, a Director at Q Squared Solutions Holdings Ltd., an Executive VP and Chief Technology & Digital Officer at Pfizer Inc., and an Advisor at Pegasus Tech Ventures, Inc. In her former positions, Ms. Fonseca served as an Independent Director at TEGNA, Inc. from 2014 to 2023, a Director at Gannett Co., Inc. from 2014 to 2016, a Director at Q2 Solutions from 2016 to 2018, the Chief Information Officer & Senior Vice President at Laboratory Corp. of America Holdings from 2008 to 2013, the Chief Information Officer & Senior Vice President at Quest Diagnostics, Inc. from 2014 to 2018, the Chief Information Officer at Philips Medical Systems from 1997 to 2005, and the Executive VP-Global Operations & Technology at Synexus Compass, Inc. in 2008. She also held positions as Vice President-Supply Chain Management at Nuclear Medicine Professionals, Inc. and as a Founding Member at Synaptic Health Alliance. Ms. Fonseca obtained an undergraduate degree from the University of California, Berkeley and an MBA from the Rotterdam School of Management. |
| Mikael Dolsten |
Mikael Dolsten is currently an Independent Director at Agilent Technologies, Inc., a Director at Research!America, a Director at PhRMA Foundation, and an Independent Director at Vimian Group AB. He is also the Co-Chief Scientific Officer & President-Research at Pfizer Inc. since 2019. In addition, he serves as a Member of the Overseers Board at The Scripps Research Institute, a Member of the Governors Board at New York Academy of Sciences, a Member of the Royal Swedish Academy of Engineering Sciences, and a Member of the Government-University-Industry Research Roundtable. Previously, Dr. Dolsten was an Independent Director at Karyopharm Therapeutics, Inc. from 2015 to 2021. He also held the position of Senior Vice President at Wyeth LLC from 2008 to 2009. He served as a Global Vice President at AstraZeneca PLC and as a Principal at OrbiMed Advisors LLC in 2008. Additionally, he was a Senior Vice President at Wyeth Pharmaceuticals LLC from 2008 to 2009. Prior to that, he was the Executive VP & Head of Worldwide Research at Boehringer Ingelheim Pharmaceuticals, Inc. from 2003 to 2008. He also held positions as President at Wyeth Research in 2008 and as a Partner at OrbiMed Advisors Private Equity in 2008. Dr. Dolsten obtained a doctorate degree from the University of Lund. |
| Douglas M. Lankler |
Douglas M. Lankler is currently the EVP, Chief Compliance & Risk Officer at Wyeth LLC. He also holds the position of Executive Vice President & General Counsel at Pfizer Inc., which he started in 1999. Prior to his current roles, he worked as an Assistant Attorney at the US Department of Justice. Lankler completed his undergraduate studies at The State University of New York and obtained his graduate degree from Cornell Law School. |
| David M. Denton |
David M. Denton is currently a Non-Executive Director at Haleon Plc and the Chief Financial Officer & Executive Vice President at Pfizer Inc. He was previously an Independent Director at Tapestry, Inc., the Chief Financial Officer & Executive Vice President at Lowe's Companies, Inc., CVS Health Corp., CVS Pharmacy, Inc., and Caremark PhC LLC. Denton received his undergraduate degree from Kansas State University and his MBA from The Wake Forest University School of Business. |
| Sally Susman |
Sally Susman is currently the Vice Chairman at The Pfizer Foundation, Inc., the Co-Chairman at International Rescue Committee, Inc., the Director at Parsons The New School for Design, the Director at U.S.-India Business Council, the Director at National Partnership for Women & Families, the Director at Alzheimers Drug Discovery Foundation, the Director at The Library of Congress Trust Fund Board, the Director at UL LLC, the Independent Director at UL Solutions, Inc., and a Trustee at Connecticut College. She previously worked as the Chief Corporate Affairs Officer & Executive VP at Pfizer Inc., the Director-International Council at US Department of State, the Director at The New York Botanical Garden, an Independent Non-Executive Director at WPP Plc, the Executive Vice President-Global Communications at The Estée Lauder Companies, Inc., a Trustee at Equity Office Properties Trust, the Deputy Assistant Secretary at US Department of Commerce, and a Legislative Assistant at US Senate Committee on Commerce, Science & Transportation. Ms. Susman completed her undergraduate degree at Connecticut College. |
| Christopher J. Stevo |
Christopher J. Stevo is currently the Chief Investor Relations Officer & Senior VP at Pfizer Inc. Prior to this, he worked as a Vice President & Senior Equity Analyst at Amundi Asset Management US, Inc. from 2012 to 2020, and as a Senior Vice President & Portfolio Manager at Putnam Investment Management LLC from 1999 to 2012. He also worked as an Analyst at Enron Corp. in 1997. In 2020, he briefly worked as the Head-Investor Relations at Alexion Pharmaceuticals, Inc. Mr. Stevo holds an MBA degree from The University of Chicago Booth School of Business and an undergraduate degree from The Wharton School of the University of Pennsylvania. |
| Suneet Varma |
Suneet Varma is an Independent Director at Cerevel Therapeutics Holdings, Inc. He is also a Director at Cerevel Therapeutics, Inc. and a Trustee at Drew University and Kent Place School, Inc. Previously, he served as the President-US Oncology Business Unit at Pfizer Inc. and held positions as a Director at The Advertising Council, Inc. and President & General Manager at Pfizer Consumer Healthcare (United Kingdom). Mr. Varma completed his undergraduate degree at Tufts University and earned an MBA from Harvard Business School. |
| Susan D. Desmond-Hellmann |
Susan D. Desmond-Hellmann is an Independent Director at Pfizer Inc. and a Director at Bill & Melinda Gates Medical Research Institute, Gates Medical Research Institute, National Resilience, Inc., and Advisor at GV Management Co. LLC. She was the Chief Executive Officer at Bill & Melinda Gates Foundation Trust and Bill & Melinda Gates Foundation Trust (Investment Management) from 2014 to 2020. She was also an Independent Director at Procter & Gamble Co. from 2011 to 2017, a Director at Affymetrix, Inc. from 2004 to 2009, and the Lead Independent Director at Meta Platforms, Inc. from 2015 to 2019. She served as the President-Product Development at Genentech, Inc. from 2005 to 2009 and as the Chancellor at The University of California, San Francisco from 2009 to 2014. She was also an Associate Director-Clinical Cancer Research at Bristol-Myers Squibb Pharmaceutical Research Institute. She holds a graduate degree from the University of California, Berkeley, and undergraduate and doctorate degrees from the University of Nevada. |
| Helen H. Hobbs |
Helen H. Hobbs is an Independent Director at Pfizer Inc. since 2011. She is also a Professor & Director-McDermott Center at The University of Texas Southwestern Medical Center. Additionally, she is a Director at Atavistik Bio, Inc. and a Member of the Association of American Physicians and the American Society of Clinical Investigation. She also serves as a Science Partner at The Column Group LLC. Dr. Hobbs completed her undergraduate degree at Stanford University and her doctorate at Case Western Reserve University. |
| James Quincey |
James Quincey is currently the Chairman & Chief Executive Officer at The Coca-Cola Co. since 2019. He is also an Independent Director at Pfizer Inc. since 2020. Additionally, he holds director positions at Special Olympics, Inc., Catalyst, Inc., Chamber of Commerce of The United States of America, US-China Business Council, Atlanta Committee for Progress, and is a Member of The Business Roundtable. Previously, he served as Co-Chairman at The Consumer Goods Forum from 2021 to 2023. He also held director positions at Fresh Trading Ltd. and Kalchas Group. Mr. Quincey completed his undergraduate degree at The University of Liverpool. |
| Joseph J. Echevarria |
Joseph J. Echevarria is currently the Chief Executive Officer at the University of Miami and the University of Miami Health System. He is also the Non-Executive Chairman at The Bank of New York Mellon Corp. Additionally, he serves as the Chairman of My Brother's Keeper Alliance, an Independent Director at Pfizer Inc., Unum Group, and Xerox (Nederland) BV. In his former positions, Mr. Echevarria served as the Chief Executive Officer at Deloitte LLP (New York) from 2011 to 2014. He was also a Director at Xerox Corp. and an Independent Director at Xerox Holdings Corp. from 2017 to 2023. Furthermore, he was a Trustee at the University of Miami from 2012 to 2019 and a Member of the US Election Assistance Commission and the President's Export Council. Mr. Echevarria obtained his undergraduate degree from the University of Miami in 1978. |
| Dan R. Littman |
Dan R. Littman is the founder of Orca Pharmaceuticals Ltd. (2012), Vedanta Biosciences, Inc. (2010), and Immunai, Inc. (2018). His current jobs include serving as an Independent Director at Pfizer Inc. (since 2018), being a member of the Scientific Advisory Board at ChemoCentryx, Inc., and being a member of the National Academy of Sciences and the National Academy of Medicine (United States). He is also a Professor at NYU Langone Medical Center (since 1995) and a Venture Partner at Catalio Capital Management LP. Dr. Littman's former job was as a Professor of Microbiology & Immunology at the University of California (1985-1995). He received his undergraduate degree from Princeton University and his doctorate from Washington University School of Medicine. |
| James C. Smith |
James C. Smith is currently the President & Chief Executive Officer at Refinitiv Transaction Services Ltd. He is also the Chairman at Thomson Reuters Foundation, an Independent Director at Pfizer Inc., a Director at Brazil US Business Council, Partnering Against Corruption Initiative, King (Cayman) Holdings Ltd., a Trustee at The Brookings Institution, and a Member-International Business Council at The World Economic Forum USA, Inc. Previously, he was the President & CEO-Academic & Reference Group at Cengage Learning, Inc. and the President & Non-Independent Director at Thomson Reuters Corp. He also served as the Chief Operating Officer at Thomson Corp. and the Head-Operations at Thomson Newspapers Ltd. Additionally, he was a Director at Refinitiv Ltd. and a Member-International Business Council at Forum Mondial de L'Economie. Mr. Smith received his undergraduate degree from Marshall University. |
| Susan J. Hockfield |
Susan J. Hockfield is currently serving as the Co-Chairman of the Advanced Manufacturing Partnership Steering Committee. She is also an Independent Director at Pfizer Inc., and serves as a Director at the Whitehead Institute for Biomedical Research, Mass General Brigham, Inc., The Charles Stark Draper Laboratory, Inc., Boston Symphony Orchestra, Inc., Repertoire Immune Medicines, Inc., Commonwealth Cancer Consortium, Inc., and Cajal Neuroscience, Inc. Previously, Dr. Hockfield served as the President of the Massachusetts Institute of Technology from 2004 to 2012. She also held positions as an Independent Director at GE Aerospace from 2006 to 2018, QUALCOMM, Inc. from 2012 to 2016, and as a Director at The National Geographic Society, Inc., WGBH Educational Foundation, Council on Foreign Relations, Inc., Woods Hole Oceanographic Institution, and Carnegie Corp. of New York. Dr. Hockfield's education includes an undergraduate degree from Rochester Christian University and a doctorate from Georgetown University School of Medicine. |
| Scott Gottlieb |
Scott Gottlieb is currently an Independent Director at Pfizer Inc., Illumina, Inc., and Tempus Labs, Inc. He is also a Director at The Mount Sinai Medical Center, Inc., Aetion, Inc., and National Resilience, Inc. Additionally, he serves as a Special Partner at NEA Management Co. LLC and is a Member of the National Academy of Medicine (United States). In the past, Dr. Gottlieb held positions as an Independent Director at CombiMatrix Corp., Managing Director at T.R. Winston & Co., Inc., and Independent Member of the Board of Directors at Bravo Health, Inc. He also served as a Member of the Board of Directors at MedAvante, Inc., Molecular Insight Pharmaceuticals, Inc., American Pathology Partners, Inc., Gradalis, Inc., Tolero Pharmaceuticals, Inc., and Daiichi Sankyo, Inc. Furthermore, he was a Director at Aseko, Inc. and Targeted Medical Pharma, Inc. Dr. Gottlieb worked as an Analyst at Alex. Brown & Sons, Inc. and as a Senior Adviser to the Administrator at the Centers for Medicare & Medicaid Services (US). He held the position of Deputy Commissioner-Medical & Scientific Affairs at the US Food & Drug Administration from 2005 to 2007 and served as the Commissioner from 2017 to 2019. Dr. Gottlieb completed his undergraduate studies at Wesleyan University and earned a doctorate degree from the Icahn School of Medicine at Mount Sinai. |
| Ronald Edward Blaylock |
Ronald Edward Blaylock is the founder and the Managing Partner of GenNx360 Management Company LLC, which was founded in 2006. He is currently the Chairman of Miller Environmental Group, Inc., ITsavvy LLC, and serves as an Independent Director for W.R. Berkley Corp., Pfizer Inc., and CarMax, Inc. He also holds positions as a Director for various organizations including the Congressional Black Caucus Foundation, Inc., Harbourton Mortgage Investment Corp., syncreon International Group Ulc, Novel Ingredient Services LLC, Mebane Charitable Foundation, B2B, New York University, Prep for Prep, The Leonard N Stern School of Business, and The Carnegie Hall Corp. Mr. Blaylock has previously served as the Chairman & Chief Executive Officer of Blaylock & Co, Inc. and as a Director for FHC Delaware, Inc., Urban One, Inc., Covenant House, Inner-City Scholarship Fund, syncreon. US, Inc., syncreon Global Holdings Ltd., Conyers Park II Acquisition Corp., Advantage Solutions, Inc. (California), The Mental Health Coalition Inc, UBS Americas, Inc., Citigroup Global Markets, Inc. (Broker), PaineWebber, Inc., Georgetown University, National Association of Basketball Coaches, The Carnegie Hall Society, Inc., and Ballet Theatre Foundation, Inc. Mr. Blaylock has an undergraduate degree from Georgetown University and an MBA from The Leonard N Stern School of Business. |
| Shantanu Narayen |
Shantanu Narayen is the founder of Pictra, Inc. (founded in 1996). He is currently the Chairman & Chief Executive Officer at Adobe, Inc. (since 1998) and Chairman of Adobe Foundation. He also serves as Vice Chairman of US India Strategic Partnership Forum. Additionally, he is the Lead Independent Director at Pfizer Inc. (since 2013) and a Director at Adobe Systems Software Ireland Ltd. Mr. Narayen previously held positions as an Independent Director at Dell, Inc. (2009-2013), Director-Desktop & Collaboration Products at Silicon Graphics, Inc., Director at Metavante Technologies, Inc. (2007-2009), and Principal at Apple, Inc. He holds a graduate degree from Bowling Green State University, an undergraduate degree from Osmania University, and an MBA from Haas School of Business. |
| Suzanne Nora Johnson |
Suzanne Nora Johnson is currently the Chairman at Intuit, Inc., Co-Chairman-Trustees Board at The Brookings Institution, Chairman at The John & Mary R. Markle Foundation, Inc., Independent Director at Pfizer Inc., Treasurer & Director at TechnoServe, Inc., Director at Pfizer, Inc., Director at Americas Frontier Fund, Trustee at the University of Southern California, Member of the American Academy of Arts & Sciences, Member of The World Economic Forum USA, Inc., Member of the American Red Cross, Inc., and Member of the Global Agenda Council. Previously, she served as Vice Chairman at The Goldman Sachs Group, Inc., Chairman at Global Markets Institute, Independent Director at American International Group, Inc., Director-Governing Board at The American National Red Cross, and Independent Director at Visa, Inc. She also held positions as Director at The Goldman Sachs Foundation and Co-Chair-Trustees Board at Carnegie Institution of Washington. Ms. Johnson completed her undergraduate studies at the University of Southern California and obtained a graduate degree from Harvard Law School. |
